Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.17

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.17. Revenue for the quarter came in at $40 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Yum! Brands completes Pizza Hut sale to LongRange for $1.5B
• USA Compression Partners LP (USAC) PT Raised to $31 at RBC Capital